Brief Article
Copyright ©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Aug 7, 2013; 19(29): 4737-4744
Published online Aug 7, 2013. doi: 10.3748/wjg.v19.i29.4737
Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation
Ho Joong Choi, Dong Goo Kim, Gun Hyung Na, Jae Hyun Han, Tae Ho Hong, Young Kyoung You
Ho Joong Choi, Dong Goo Kim, Gun Hyung Na, Jae Hyun Han, Tae Ho Hong, Young Kyoung You, Hepatobiliary-Pancreas Surgery and Liver Transplantation Division, Department of Surgery, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul 137-701, South Korea
Author contributions: Choi HJ designed the study, analyzed the data, performed the study, and wrote the paper; Na GH, Han JH, Hong TH and You YK collected the data; Kim DG designed the study, collected the data, and wrote the paper.
Correspondence to: Dong Goo Kim, MD, PhD, Hepatobiliary-Pancreas Surgery and Liver Transplantation Division, Department of Surgery, Seoul St. Mary’s Hospital, The Catholic University of Korea, 505 Banpo-dong, Seocho-gu, Seoul 137-701, South Korea. kimdg@catholic.ac.kr
Telephone: +82-2-22586102 Fax: +82-2-5952992
Received: February 21, 2013
Revised: April 12, 2013
Accepted: June 1, 2013
Published online: August 7, 2013
Core Tip

Core tip: Liver transplantation (LT) for hepatocellular carcinoma (HCC) is known to be the best therapeutic option. To obtain a good result, it is important to select appropriate LT candidates from among HCC patients. For living-donor liver transplantation (LDLT), investigation of the efficacy of such criteria will facilitate adoption of extended criteria in LDLT. We defined the selection criteria according to risk factors for recurrence based on our results and compared them with other criteria or scoring systems, such as the Milan and University of California, San Francisco criteria, tumor node metastasis and Barcelona Clinic Liver Cancer staging, and the Cancer of the Liver Italian Program scoring system.